Jeffrey Wong, MD, discusses findings on the use of Cu 64 anti-CEA M5A as a PET imaging agent for advanced rectal cancer presented at the 2024 American Society for Radiation Oncology Annual Meeting.
"Tumor behavior upon recurrence is often more aggressive, and patients may quickly exhaust safe and effective options for ...
A sizeable proportion of patients with cancer who experience cognitive decline after radiation treatment for brain metastases ...
In an interview with Targeted Oncology, Jeffrey Wong, MD, discussed the potential and future directions of Cu 64 anti-CEA M5A ...
HealthDay on MSN23h
ASTRO: Hypofractionated Radiation Therapy Safe After Breast ReconstructionFor patients undergoing breast reconstruction, a 16-fraction course of hypofractionated postmastectomy radiation therapy ...
A radionuclide agent, Lu-177 dotatate was approved by the FDA in 2018 for gastroenteropancreatic neuroendocrine tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback